SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-21-006406
Filing Date
2021-02-17
Accepted
2021-02-17 16:49:48
Documents
73
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K vktx-10k_20201231.htm   iXBRL 10-K 2781727
2 EX-4.5 vktx-ex45_8.htm EX-4.5 66131
3 EX-23.1 vktx-ex231_6.htm EX-23.1 3111
4 EX-31.1 vktx-ex311_7.htm EX-31.1 20330
5 EX-31.2 vktx-ex312_9.htm EX-31.2 20309
6 EX-32.1 vktx-ex321_10.htm EX-32.1 12675
7 GRAPHIC gw5rupjpmffd000001.jpg GRAPHIC 45548
  Complete submission text file 0001564590-21-006406.txt   10186460

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA vktx-20201231.xsd EX-101.SCH 64739
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vktx-20201231_cal.xml EX-101.CAL 56629
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vktx-20201231_def.xml EX-101.DEF 209205
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE vktx-20201231_lab.xml EX-101.LAB 492560
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vktx-20201231_pre.xml EX-101.PRE 381695
13 EXTRACTED XBRL INSTANCE DOCUMENT vktx-10k_20201231_htm.xml XML 1966511
Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37355 | Film No.: 21645599
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences